Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-01-01 Option Award | 2024-01-02 4:12 pm | N/A N/A | Apellis Pharmaceuticals Inc. | APLS | O'Brien Stephanie Monaghan Director | 3,341 | $0 | 17,186 (Direct) | View |
| 2024-01-01 Option Award | 2024-01-02 4:12 pm | N/A 2030-12-31 | Apellis Pharmaceuticals Inc. | APLS | O'Brien Stephanie Monaghan Director | 5,748 | $59.86 | 17,186 (Direct) | View |
| 2023-01-01 Option Award | 2023-01-04 5:33 pm | N/A 2030-12-31 | Apellis Pharmaceuticals Inc. | APLS | O'Brien Stephanie Monaghan Director | 11,308 | $0 | 15,538 (Direct) | View |
| 2022-01-01 Option Award | 2022-01-04 4:41 pm | N/A 2029-12-31 | Apellis Pharmaceuticals Inc. | APLS | O'Brien Stephanie Monaghan Director | 12,784 | $0 | 12,784 (Direct) | View |
| 2021-01-01 Option Award | 2021-01-04 7:21 pm | N/A 2030-12-31 | Apellis Pharmaceuticals Inc. | APLS | O'Brien Stephanie Monaghan Director | 27,600 | $0 | 27,600 (Direct) | View |
| 2020-01-01 Option Award | 2020-01-03 4:31 pm | N/A 2029-12-31 | Apellis Pharmaceuticals Inc. | APLS | O'Brien Stephanie Monaghan Director | 27,600 | $30.62 | 27,600 (Direct) | View |